MIM
BCYC

Monashee Investment Management’s Bicycle Therapeutics BCYC Stock Holding History

Monashee Investment Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-52,900
Closed -$532K – 124
2019
Q2 		$532K Buy
+52,900
New +$637K 0.14% 111

Other funds holding BCYC

TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Monashee Investment Management's BCYC Position: Q3 2019 in Review

Monashee Investment Management sold out of Bicycle Therapeutics (BCYC) in Q3 2019, closing a stake of 52,900 shares — an estimated $532K sold.

Monashee Investment Management first reported a position in BCYC in Q2 2019 and held it in 1 quarter. The position peaked at $532K in Q2 2019. 11 funds tracked by Wall St. Rank hold BCYC as of Q3 2019.

  • Monashee Investment Management reported no remaining Bicycle Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Monashee Investment Management sold 52,900 Bicycle Therapeutics shares in Q3 2019, an estimated $532K.
  • Monashee Investment Management first reported a position in Bicycle Therapeutics in Q2 2019 and held it in 1 quarter.
  • Monashee Investment Management's Bicycle Therapeutics position peaked at $532K in Q2 2019.
  • 11 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2019.

Based on Monashee Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.